Objective: Self-management support is essential in rheumatoid arthritis (RA). The WebRA trial showed that digital patient education (PE) improves self-efficacy, supports self-management, and reduces outpatient visits. This study assessed the 12-month cost-effectiveness from a partial societal perspective. Methods: Adults newly diagnosed with RA were randomised to digital or face-to-face PE. Quality-adjusted life years (QALYs) were estimated from EQ-5D-5L measurements over 12 months. Costs were obtained from national registries and incremental cost-effectiveness ratios (ICERs) were calculated. The probability of cost-effectiveness was estimated using probabilistic sensitivity analysis. Minimal important change in self-efficacy was the secondary outcome. Results: Baseline characteristics of the 175 participants were balanced (intervention vs control): 60.7% vs 61.5% female, mean age 58 vs 56 years, and mean disease activity score (DAS28) 4.4 vs 4.6. Digital PE led to lower healthcare costs (€9,322 vs €9,886), and minor QALY gains (mean difference 0.013). The intervention was dominant in both adjusted and crude models, with ICERs of -€43,692/QALY and -€24,056/QALY, respectively. In bootstrap analyses, 47.3% (adjusted) and 52.7% (crude) of iterations fell in the south-east quadrant (lower costs, better outcomes). Probability of cost-effectiveness reached 71.5% at a €22,665/QALY threshold. For self-efficacy, digital PE was cost-saving, but effects were small and inconsistent. Conclusions: Digital PE was associated with lower costs and a small QALY gain compared with face-to-face PE, with a moderate probability of cost-effectiveness. Digital PE may be a cost-effective alternative; however, the estimated effects were subject to some uncertainty and sensitivity to model specification. Further investigation in broader populations is warranted.